Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
bioresorbable stent
MedTech
R3 Vascular raises $87M for bioresorbable, below-the-knee stent
On the heels of a groundbreaking FDA approval for a major medtech, a Silicon Valley startup is shaping up to be a possible competitor.
Conor Hale
May 17, 2024 12:31pm
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
Reva returns with $45M to bring its dissolving stent to the US
Aug 10, 2022 11:46am
Lyra Therapeutics wants a $58M IPO
Mar 9, 2020 8:25am
Reva expands bioresorbable stent footprint in Europe
Jan 8, 2019 11:34am
Reva secures CE mark for bioresorbable scaffold in lower-leg PAD
Jul 30, 2018 12:23pm
